Skip to main content
NCBI home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1993 Nov;69(5 Spec No):518–520. doi: 10.1136/adc.69.5_spec_no.518

Inhaled nitric oxide for pulmonary hypertension after repair of exomphalos.

O I Miller 1, J W Gaynor 1, D J Macrae 1, R C Tasker 1
PMCID: PMC1029596  PMID: 8285756

Abstract

Inhaled nitric oxide was used successfully to treat a newborn infant with severe pulmonary hypertension complicating repair of congenital exomphalos. The infant had failed conventional treatment and extracorporeal membrane oxygenation was unsuitable because of the risk of bleeding from the recent laparotomy. Extended treatment with inhaled nitric oxide appears safe and may offer an alternative to mechanical life support in severe cases of neonatal pulmonary hypertension.

Full text

PDF
518

Images in this article

518Image
on p.518

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Celermajer D. S., Cullen S., Deanfield J. E. Impairment of endothelium-dependent pulmonary artery relaxation in children with congenital heart disease and abnormal pulmonary hemodynamics. Circulation. 1993 Feb;87(2):440–446. doi: 10.1161/01.cir.87.2.440. [DOI] [PubMed] [Google Scholar]
  2. Hopkins R. A., Bull C., Haworth S. G., de Leval M. R., Stark J. Pulmonary hypertensive crises following surgery for congenital heart defects in young children. Eur J Cardiothorac Surg. 1991;5(12):628–634. doi: 10.1016/1010-7940(91)90118-4. [DOI] [PubMed] [Google Scholar]
  3. Ignarro L. J. Biological actions and properties of endothelium-derived nitric oxide formed and released from artery and vein. Circ Res. 1989 Jul;65(1):1–21. doi: 10.1161/01.res.65.1.1. [DOI] [PubMed] [Google Scholar]
  4. Kinsella J. P., Neish S. R., Shaffer E., Abman S. H. Low-dose inhalation nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 3;340(8823):819–820. doi: 10.1016/0140-6736(92)92687-b. [DOI] [PubMed] [Google Scholar]
  5. Lafferty P. M., Emmerson A. J., Fleming P. J., Frank J. D., Noblett H. R. Anterior abdominal wall defects. Arch Dis Child. 1989 Jul;64(7):1029–1031. doi: 10.1136/adc.64.7.1029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Miller O. I., James J., Elliott M. J. Intraoperative use of inhaled low-dose nitric oxide. J Thorac Cardiovasc Surg. 1993 Mar;105(3):550–551. [PubMed] [Google Scholar]
  7. Moncada S., Radomski M. W., Palmer R. M. Endothelium-derived relaxing factor. Identification as nitric oxide and role in the control of vascular tone and platelet function. Biochem Pharmacol. 1988 Jul 1;37(13):2495–2501. doi: 10.1016/0006-2952(88)90236-5. [DOI] [PubMed] [Google Scholar]
  8. Roberts J. D., Polaner D. M., Lang P., Zapol W. M. Inhaled nitric oxide in persistent pulmonary hypertension of the newborn. Lancet. 1992 Oct 3;340(8823):818–819. doi: 10.1016/0140-6736(92)92686-a. [DOI] [PubMed] [Google Scholar]
  9. Rossaint R., Falke K. J., López F., Slama K., Pison U., Zapol W. M. Inhaled nitric oxide for the adult respiratory distress syndrome. N Engl J Med. 1993 Feb 11;328(6):399–405. doi: 10.1056/NEJM199302113280605. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES